Welcome to the Intellectual Property Litigation Newsletter, our review of decisions and trends in the intellectual property arena.
In this edition, we learn that unilateral assertion is not industry standard, the IPR...more
Welcome to the Intellectual Property Litigation Newsletter, our review of decisions and trends in the intellectual property arena.
In this edition, we learn that that changing a definition has consequences, an apex...more
1/17/2025
/ Copyright ,
Food and Drug Administration (FDA) ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Trademark Litigation ,
USPTO